Methods: Subjects were COVID-19 patients with suspected Omicron variant infection that
were hospitalized at Dr. Moewardi General Hospital, Surakarta, from October 2021 to March …

Background: Researchers have already reported a high level of interleukin (IL)-6 in patients
affected by Coronavirus Disease 2019 (COVID-19). In this study, we investigated the surge …

Background: The objective of this study was to estimate the Interleukin-6 levels of COVID 19
patients and to find any associations between Interleukin-6 levels and age, gender, co …

Background Evidence links COVID-19 severity to hyper-inflammation. Treatment with
tocilizumab, a monoclonal antibody directed against the interleukin-6 (IL-6) receptor, was …

Objectives: Interleukin 6 (IL-6) plays a leading role in the proliferation and differentiation of
immune cells. Level of IL-6 is manifestly increased under many inflammatory conditions …

COVID-19 is an acute infectious respiratory disease caused by the severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) virus. Changes in inflammatory mediators in the …

Background: COVID-19 is a highly infectious viral infection caused by SARS-CoV-2 that can
affect persons of all ages, from infants to the elderly, resulting in various clinical …

Background: Interleukin-6 (IL-6) is a pro-inflammatory cytokine that is produced at varying
levels in patients with coronavirus disease 2019 (COVID-19). The neutrophil–lymphocyte …

Aims: This study was aimed to measure and evaluate the serum interleukin-6 level in
diagnosed cases of COVID-19 Patients. Study design: An observational study. Place and …

Materials and methods This cross-sectional study included a total of 60 confirmed cases of
COVID-19, comprising 30 severe cases (Group A) and 30 non-severe cases (Group B), and …